BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9062474)

  • 1. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma.
    Russo D; Tumino S; Arturi F; Vigneri P; Grasso G; Pontecorvi A; Filetti S; Belfiore A
    J Clin Endocrinol Metab; 1997 Mar; 82(3):735-8. PubMed ID: 9062474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Val 677 activating mutation of the thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis.
    Russo D; Wong MG; Costante G; Chiefari E; Treseler PA; Arturi F; Filetti S; Clark OH
    Thyroid; 1999 Jan; 9(1):13-7. PubMed ID: 10037070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma.
    Baloch Z; Livolsi VA
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3906-8. PubMed ID: 9360562
    [No Abstract]   [Full Text] [Related]  

  • 4. Activating mutations of the TSH receptor in differentiated thyroid carcinomas.
    Russo D; Arturi F; Schlumberger M; Caillou B; Monier R; Filetti S; Suárez HG
    Oncogene; 1995 Nov; 11(9):1907-11. PubMed ID: 7478621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does a Leu 512 Arg thyrotropin receptor mutation cause an autonomously functioning papillary carcinoma?
    Gozu H; Avsar M; Bircan R; Sahin S; Ahiskanali R; Gulluoglu B; Deyneli O; Ones T; Narin Y; Akalin S; Cirakoglu B
    Thyroid; 2004 Nov; 14(11):975-80. PubMed ID: 15671779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas.
    Russo D; Arturi F; Suarez HG; Schlumberger M; Du Villard JA; Crocetti U; Filetti S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1548-51. PubMed ID: 8636365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism.
    Camacho P; Gordon D; Chiefari E; Yong S; DeJong S; Pitale S; Russo D; Filetti S
    Thyroid; 2000 Nov; 10(11):1009-12. PubMed ID: 11128715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation.
    Spambalg D; Sharifi N; Elisei R; Gross JL; Medeiros-Neto G; Fagin JA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3898-901. PubMed ID: 8923835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary culture of cells from hyperfunctioning thyroid adenoma with an activating mutation of G alphas.
    Kamiya Y; Murakami M; Yanagita Y; Koitabashi H; Nagamachi Y; Hosoi Y; Ogiwara T; Mizuma H; Iriuchijima T; Mori M
    Mol Cell Endocrinol; 1998 Mar; 138(1-2):137-42. PubMed ID: 9685222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620I) and a mutation of the Ki-RAS (G12C) genes.
    Niepomniszcze H; Suárez H; Pitoia F; Pignatta A; Danilowicz K; Manavela M; Elsner B; Bruno OD
    Thyroid; 2006 May; 16(5):497-503. PubMed ID: 16756473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low incidence of the stimulatory G protein alpha-subunit mutations in autonomously functioning thyroid adenomas in Japan.
    Tanaka K; Nagayama Y; Takeshita A; Namba H; Yamashita S; Niwa M; Nagataki S
    Thyroid; 1996 Jun; 6(3):195-9. PubMed ID: 8837326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence of thyrotropin receptor and G(s alpha) gene mutation in high iodine uptake thyroid carcinoma.
    Bourasseau I; Savagner F; Rodien P; Duquenne M; Reynier P; Guyetant S; Bigorgne JC; Malthièry Y; Rohmer V
    Thyroid; 2000 Sep; 10(9):761-5. PubMed ID: 11041453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
    Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
    Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations in N-bis(2-hydroxypropyl)nitrosamine-induced rat transplantable thyroid carcinoma lines: analysis of the TSH-R, G(alpha)s, ras and p53 genes.
    Kitahori Y; Naitoh H; Konishi N; Ohnishi T; Hiasa Y
    Carcinogenesis; 1997 Feb; 18(2):265-9. PubMed ID: 9054617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms.
    Tonacchera M; Vitti P; Agretti P; Ceccarini G; Perri A; Cavaliere R; Mazzi B; Naccarato AG; Viacava P; Miccoli P; Pinchera A; Chiovato L
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4155-8. PubMed ID: 10566665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic alterations in thyroid hyperfunctioning adenomas.
    Russo D; Arturi F; Wicker R; Chazenbalk GD; Schlumberger M; DuVillard JA; Caillou B; Monier R; Rapoport B; Filetti S
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1347-51. PubMed ID: 7714109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas from Brazil.
    Nogueira CR; Kopp P; Arseven OK; Santos CL; Jameson JL; Medeiros-Neto G
    Thyroid; 1999 Nov; 9(11):1063-8. PubMed ID: 10595453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
    Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan.
    Takeshita A; Nagayama Y; Yokoyama N; Ishikawa N; Ito K; Yamashita T; Obara T; Murakami Y; Kuma K; Takamatsu J
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2607-11. PubMed ID: 7673402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
    Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.